PD-BT2278

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NamePD-BT2278
Drug Alias NamePD-BT2278
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionSynuclein alpha inhibitorsNeuroprotectants
TargetsSynuclein alpha
Therapy Area/IndicationsParkinson DiseaseLewy Body DiseaseMultiple System Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBioarctic Ab
China Registration ClassN/A

Develop Information

Active CompaniesBioarctic Ab
Inactive CompaniesN/A
Active IndicationsParkinson DiseaseLewy Body DiseaseMultiple System Atrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A